Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by A B Skotnicki
Status of Minimal Residual Disease Determines Outcome of Autologous Hematopoietic SCT in Adult ALL
Bone Marrow Transplantation
Transplantation
Hematology
Related publications
Do Cytogenetics Predict Likelihood to Attain Minimal Residual Disease (MRD) Post Autologous Stem Cell Transplantation (SCT) in Multiple Myeloma (MM)?
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Minimal Residual Disease
Leukemia Supplements
Minimal Residual Disease
Bone Marrow Transplantation
Transplantation
Hematology
Quantification of Minimal Residual Disease Levels by Flow Cytometry at Time of Transplant Predicts Outcome After Myeloablative Allogeneic Transplantation in ALL
Bone Marrow Transplantation
Transplantation
Hematology
Monitoring of Minimal Residual Disease in Multiple Myeloma After Allo-Sct: Flow Cytometry vs PCR-based Techniques
Bone Marrow Transplantation
Transplantation
Hematology
Different Impact of BCR‐ABL Transcripts on Allogeneic Hematopoietic Cell Transplantation From Different Graft Sources for Ph+ALL With Minimal Residual Disease
American Journal of Hematology
Hematology
Monitoring of Minimal Residual Disease (MRD) Is Useful to Predict Prognosis of Adult Patients With Ph-Negative ALL: Results of a Prospective Study (ALL MRD2002 Study)
Journal of Hematology and Oncology
Cancer Research
Oncology
Hematology
Molecular Biology
Molecular Minimal Residual Disease Negativity and Decreased Stem Cell Mobilization Potential Predict Excellent Outcome After Autologous Transplant in NPM1 Mutant Acute Myeloid Leukemia.
Haematologica
Hematology
Workshop on Minimal Residual Disease
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
